Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine

BACKGROUND/PURPOSE: The efficacy and safety of coronavirus disease 2019 (COVID-19) booster vaccines remain limited. We investigated the immunogenicity and adverse events of the third dose of mRNA vaccines in healthy adults. METHODS: Volunteers vaccinated with two doses of the adenoviral vaccine (ChA...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Wang-Huei, Ieong, Si-Man, Lin, Pin-Hung, Hsieh, Ming-Ju, Yang, Hung-Chih, Pan, Ching-Fu, Chao, Tai-Ling, Chang, Sui-Yuan, Chang, Shan-Chwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Formosan Medical Association. Published by Elsevier Taiwan LLC. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452412/
https://www.ncbi.nlm.nih.gov/pubmed/36127206
http://dx.doi.org/10.1016/j.jfma.2022.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452412/
https://www.ncbi.nlm.nih.gov/pubmed/36127206
http://dx.doi.org/10.1016/j.jfma.2022.09.004

Ejemplares similares